'Hypertension drugs' diaporamas de présentation

Anti-Hypertensive Drug Demand in Latin America

Anti-Hypertensive Drug Demand in Latin America. William H. Dow University of California, Berkeley January 2009. What Do We Know About Drug Use Rates?. Latin America has ~8% of world pharmaceutical market Child vaccines: >75% of world children receive, but requires major campaigns.

377 views • 23 slides

Hypertension Drugs Markets Analysis

Analyze Future: Hypertension Drugs Markets in China To get More Details @ http://www.analyzefuture.com/hypertension-drugs-in-china-market China's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.

237 views • 9 slides

Hypertension Drugs Markets in China

272 views • 7 slides

Liver Cancer Treatment Drugs Markets in China

China's demand for Liver Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled. Detailed report at: http://www.reportsandintelligence.com/liver-cancer-treatment-drugs-in-china-market

221 views • 6 slides

Anti-hypertensive Therapeutics in APAC Markets Deals and Strategic Consolidations to 2021

Hypertension is a chronic medical condition characterized by elevated blood pressure in the arteries. It affected an estimated 517 million people in 2014, a figure that will grow at a Compound Annual Growth Rate (CAGR) of 1.2% to 561 million in 2021 in the four Asia-Pacific (APAC) regions of China, India, Australia, and Japan. This high prevalence is a substantial contributor to healthcare costs and a major cause of morbidity. Despite this, awareness of hypertension is low among physicians, patients, and the public alike, leading to poor blood pressure control

176 views • 6 slides

Portal Hypertension Pipeline Review H2 2015

This report provides comprehensive information on the therapeutic development for Portal Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases

206 views • 6 slides

Global Hypertension Drugs Market 2015 Industry Analysis, Research, Trends, Growth and Forecasts

197 views • 6 slides